Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Neuroone Medical Technologies Corp fell by 2.84m. Cash Flow from Financing totalled 7.40m or 214.57% of revenues. In addition the company used 12.89m for operations while cash from investing totalled 2.65m.
Cash flow per share | -0.4766 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1082 |
---|---|
Tangible book value per share | 0.1055 |
More ▼
Balance sheet in USDView more
Current ratio | 2.42 |
---|---|
Quick ratio | 1.36 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼